See also this year's filing and all EDGAR filings for this company.
PDF Report 0001509190_2016_Aratana_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001509190, Aratana Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 89,019,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 54,848,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,555,000 |
| 3 | remainder_Assets | 644,000 |
| 4 | LiabilitiesCurrent | 5,684,000 |
| 5 | LiabilitiesNoncurrent | 122,000 |
| 6 | remainder_Liabilities | 39,710,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,819,000 |
| 9 | ResearchAndDevelopmentExpense | 24,964,000 |
| 10 | remainder_Expenses | 43,693,000 |
| 11 | remainder_Revenues | 678,000 |
| 12 | remainder_NetIncome | 3,744,000 |
| 13 | remainder_ComprehensiveNetIncome | -5,170,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 147,066,000 |
| 1 | Liabilities | 45,516,000 |
| 2 | Expenses | 88,476,000 |
| 3 | Revenues | 678,000 |
| 4 | StockholdersEquity | 101,550,000 |
| 5 | NetIncome | -84,054,000 |
| 6 | ComprehensiveNetIncome | -86,639,000 |
| 7 | BaseVar | 145,325,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.40 |
| 9 | EconomicCapitalRatio | 2.61 |
Edgar->Model Mapping
Feature Distribution
Change over Time
